Apple’s iPad is, and will be, a huge catalyst for change in pharma marketing for 2011 and beyond. I’m not suggesting that Apple will rule the category, there are several other viable “tablet/slates” coming to market as Leigh mentioned in her recent blog entry. However, I want to point out the impact of Apple is having on an industry.
In the lab we talk about trending and futuring – I wouldn’t call my iPad prediction a true “futuring” derivative. I’d prefer to call it “Deja Viewing” —reviewing the past to determine if anything similar has happened. Lets go back to 2001 when Apple launched the iPod. By 2004, the iPod line dominated digital music player sales in the United States, with over 90% of the market for hard drive-based players. In 2008, 42% of Apple’s $1.5 billion first quarter revenue was iPod sales. Read Full Entry
Lots of Foursquare users love the game of it. They click their checkins. Fight their caffeinated foes for mayorship of the Crimson Cup. Follow the fascinating lives of their friends and followers as they bounce from place to place on the gameboard of their city.
It’s a delightful piece of social connection that can be all too easily ruined by: The Blank Stare. Say you just got dubbed a Gym Rat at your local Urban Active. You show your virtual badge of honor to the manager only to get … That Look. The I Have No Idea What You’re Talking About Gawk. Or worse – The Condescending Shrug. Read Full Entry
[Editor's Note: This post covers the CEOs' practices to foster Innovative within their respective companies. ]
Moving away from the CEO’s point of view on the Nation, the conversation quickly moves and focuses on each individual company. Shapiro asks the panel what gives their company a competitive edge over their competition globally.
Read Full Entry
[Editor's Note: We decided to split up this post into two. There was so much good dialogue among the panelists, we thought it would be good to share our whole experience of this keynote. This post covers the CEOs' POV on what hinders our nation's advancement as an Innovative Leader at the global level. This particular post may not directly involve pharma and pharma marketing, but they are issues that affect all industries. ]
For Friday’s opening keynote. Xerox CEO Ursula Brown, Cisco CEO John Chambers and GE CEO Jeffrey Immelt joined CEA CEO/President Gary Shapiro for an Innovation Power Panel. Read Full Entry
It goes without saying that in order to build products and solutions it’s important to have a full grasp of the foundation on which your solution will live. In order to have buy-in for you solution, stakeholders, account executives and potential clients should also have a similar grasp.
In my daily professional world I am surrounded by interactive designers, programmers and digital strategists. My peers are familiar with the higher concepts when it pertains to interactive and the web. Terms like “cloud computing,” “SVG” and “HTML5″ are not foreign words to us. For many of the people in my personal life, namely my kids, my retired parents, many of my SCUBA diving buddies, this isn’t the case. With my job, it’s important to realize that not everyone I interact knows exactly what I’m talking about.
Enter Google’s most recent PSA-like contribution:
Read Full Entry
Apple’s iPad is, and will be, a huge catalyst for change in pharma marketing for 2011 and beyond. I’m not suggesting that Apple will rule the category, there are several other viable “tablet/slates” coming to market as Leigh mentioned in her recent blog entry. However, I want to point out the impact of Apple is having on an industry.
